O

Optel Group

End-to-end product traceability systems provider

Validation Specialist - Serialization, Vision & Automated Inspection Systems

Full-Time
No salary listed
Junior
Bachelor's
Québec City, QC, Canada
In Person
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • A college diploma in a relevant field.
  • At least 2 years of experience in system testing and validation or technical writing.
  • Excellent written and spoken English proficiency.
  • Advanced knowledge of Microsoft Office, particularly Word.
  • Rigor, analytical skills, and attention to detail.
  • Ability to collaborate within a team and communicate with stakeholders at all levels.
Responsibilities
  • Develop and maintain standardized validation templates for internal use and clients that comply with industry standards and regulatory guidelines, including Good Automated Manufacturing Practice (GAMP), FDA 21 CFR Part 11, EU Annex 11, and the V-Cycle.
  • Review and interpret system updates, including new releases and hotfixes, to determine their impact on validation documents.
  • Generate client validation documents based on project functional and design specifications.
  • Execute internal validation protocols as needed to ensure system functionality and compliance.
  • Participate in risk analyses to identify risks associated with validation activities and develop mitigation strategies.
  • Identify root causes of validation non-conformities and implement corrective actions for continuous quality improvement.
  • Coordinate internal departments to deliver validation documentation at specific stages of project development.
  • Collaborate with internal teams and clients to provide guidance on validation strategies and best practices.
  • Work with the quality assurance team to align validation activities with internal quality systems and external regulatory requirements, including participation in internal and external audits.
  • Perform other tasks related to validation processes.
Desired Qualifications
  • Knowledge of macros using Visual Basic for Applications (VBA) in Word and Excel.
  • Interest and aptitude for adopting new technologies, including practical applications of artificial intelligence for task optimization.
  • Curiosity and willingness to learn and adopt new technologies, especially artificial intelligence.

About the company

O

Optel Group

View
Website

Optel provides end-to-end traceability solutions for global supply chains. It uses optical inspection, data collection, and software to track products from raw materials to the end consumer, helping ensure regulatory compliance and reduce waste. The company differentiates itself through strategic acquisitions (GeoTraceability and Verify Brand), a global manufacturing footprint, and its Certified B Corporation status. Its goal is to prevent counterfeit products, ensure regulatory compliance, and help brands optimize operations with transparent, verifiable product histories.

Company Size

501-1,000

Company Stage

Grant

Total Funding

$3M

Headquarters

Quebec City, Canada

Founded

1989

Get referred to Optel Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 17, 2026 Kaster partnership targets 20% capacity gains without new capex.
  • February 15, 2026 Techno Service deal opens Egypt's regulated pharma market before deadlines.
  • September 2026 launches and CPhI/Pack Expo 2026 demos signal active demand generation.

What critics are saying

  • Egypt's August 1, 2026 EDA deadline pressures execution; missed deployments jeopardize credibility.
  • CountSafe 360 faces incumbents with cheaper vision systems and faster software-only upgrades.
  • A failed pharma product cycle would squeeze margins and weaken Optel's standalone automation strategy.

What makes Optel Group unique

  • Optel tracks 8,000+ lines across 50 countries, anchoring deep pharma compliance trust.
  • CountSafe 360 inspects tablets 360° at 150,000 units hourly without line modification.
  • Vanguard Robotics acquisition in August 2025 adds cobots to traceability and inspection.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Employee Assistance Program
  • Flexible Work Hours
  • 401(k) Company Match
  • Commuter Benefits

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Optel Group
Sep 30th, 2026
OPTEL launches CountSafe(TM) 360: full surface tablet inspection at full line speed.

OPTEL launches CountSafe(TM) 360: full surface tablet inspection at full line speed. Quebec, September 30th, 2026 - OPTEL announced the launch of CountSafe(TM) 360, a 360° visual inspection system built for pharmaceutical and nutraceutical solid dosage manufacturers, covering tablets, capsules, softgels and gel-tabs. Its promise is simple: see every product from every angle, without ever slowing down the line. CountSafe 360 is one of the latest results of a year of OPTEL R&D focused on one goal: helping manufacturers improve efficiency without compromising quality or compliance, at a price point within reach for all sizes of operations. Nothing stays hidden. Most inspection systems only look at one side of a product. A defect on the hidden face, a malformed tuck, a capsule unlocked on the wrong side, and it slips through. CountSafe 360 rolls every unit across motorized rollers to capture its full surface before ejection. A one-millimeter stain, a chip smaller than a millimeter, a color or shape defect: none of it gets past. And to make sure every reject actually stays rejected, a second camera confirms each ejection at 100%, a safety net few systems offer. No line downtime, no implementation headaches. CountSafe 360 runs standalone: no line modification required, no downtime to deploy it. Quality teams can even build and refine inspection recipes offline, on a laptop, from a reference image set, without ever pausing production to do it. Full rigor, none of the speed trade-off. Best-in-Class quality, at a cost rethought. Where 360° inspection systems have traditionally been positioned as investments reserved for the largest players, CountSafe 360 makes that rigor accessible at a cost significantly below the competition, with no compromise on precision or throughput, up to 150,000 products per hour. "With CountSafe 360, we set out to prove that manufacturers shouldn't have to choose between efficiency, quality, and cost. A year of R&D went into making that trade-off disappear - and the result is a solution that scales from a single line to a full plant, within your budget." - Etienne Ouellet, Product Owner and R&D Supervisor, OPTEL Available now. CountSafe 360 is cGMP-ready, eligible for FDA 21 CFR Part 11 electronic records, and delivered in 14 to 16 weeks after FDS signature. For additional details, visit the CountSafe 360 product page, or get in touch with its team to learn more.

Business Insider
Sep 23rd, 2026
Petrolíferos Lobo and Oz Studio expand TRACE from petroleum into pharmaceutical and supplement traceability.

Petrolíferos Lobo and Oz Studio expand TRACE from petroleum into pharmaceutical and supplement traceability. Sep. 23, 2026, 10:00 AM New York, NY, Sept. 23, 2026 (GLOBE NEWSWIRE) - Petrolíferos Lobo and Oz Studio (Oz Branding) announced the expansion of TRACE - the Traceability, Regulatory Assurance & Custody Evidence System - from petroleum into pharmaceuticals, supplements and other health products. Daniel Osuna presenting the TRACE platform at UNGA81 The announcement follows the September 21 presentation of TRACE and its successful application to petroleum traceability in Mexico to the United Nations Office for Digital and Emerging Technologies during the 81st session of the UN General Assembly in New York. The presentation was delivered by Daniel Osuna of Oz Studio. TRACE was developed by Petrolíferos Lobo and Oz Studio to give petroleum clients greater certainty regarding the origin, documentation, regulatory consistency and chain of custody of the products they receive, particularly at a time when huachicol fiscal has cast a broader shadow over confidence in Mexico's legitimate petroleum industry. Rather than treating traceability as a collection of documents, TRACE creates an interactive evidence chain. The petroleum application follows information from purchase and importation through customs, fiscal documentation, permits, transport, driver assignment, physical seals, GPS routing and final delivery. Its verification architecture combines AI-assisted document interpretation with deterministic rules, official-source validation, cross-document comparison, cryptographic fingerprinting, digital signatures, trusted timestamps and an auditable custody ledger. Petrolíferos Lobo and Oz Studio (Oz Branding in Mexico) are now expanding the TRACE methodology into pharmaceutical and supplement provenance, with Gaston AI developing the health-sector implementation in coordination with the TRACE team. Gaston AI is a UK based AI-powered preventive health company led by Founder and CEO, Dr Yogesh Gupta. Working sessions between Dr. Gupta and Osuna took place in New York during UNGA81 to define how TRACE's verification architecture can be adapted to medicines, supplements and consumer health products. The development responds to an increasingly complex health-commerce environment. GLP-1 medicines are now used for weight loss by roughly 11% of U.S. adults, while concerns continue around counterfeit, improperly compounded and illegally marketed products sold outside authorized channels. Similar provenance issues affect supplements, counterfeit pain medications and so-called "gas station drugs." The expanded TRACE methodology is being designed to evaluate manufacturer identity, batch and lot information, laboratory documentation, regulatory status, authorized distribution, seller legitimacy, packaging identifiers and chain of custody. Gaston AI's implementation will integrate these TRACE principles into its health intelligence platform through a co-development model with the original TRACE team. It will add a medication and supplement provenance layer designed to surface verifiable evidence about the products people ingest, alongside biomarker- and nutrition-led insights. "Petroleum taught us that trust is rarely contained in one document. It exists in the relationship between documents, organizations and custody events," said Daniel Osuna. "In pharmaceuticals, that same problem becomes even more consequential because the final destination is the human body." TRACE was conceived as a scalable methodology from the outset, with pharmaceuticals and supplements identified as natural applications for batch, laboratory, import and authorized-distribution verification. This collaboration brings together TRACE's evidence-verification architecture with Gaston AI's expertise in biomarker intelligence, precision nutrition and preventive health. The principle remains simple: AI can interpret the evidence, while TRACE makes it verifiable. This collaboration reaffirms Petroliferos Lobos' commitment to traceability, flexibility, and a collaborative working model across borders and industries Daniel Osuna from Oz Studio Press Inquiries Daniel Osuna media [at] ozbranding.com +12123811969 https://oz.studio 5900 Balcones Drive Austin, TX 78731 Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Sponsored Financial Content

PR Newswire
Mar 17th, 2026
OPTEL and Kaster partner to boost pharma production capacity up to 20% with AI-driven planning

OPTEL, a global traceability and compliance solutions provider, has partnered with Kaster Technologies to bring AI-driven production planning intelligence to pharmaceutical manufacturers. The collaboration aims to help facilities increase production capacity and improve operational efficiency without additional capital investment. The partnership addresses a critical gap in pharmaceutical manufacturing, where traditional ERP systems and spreadsheet-based planning tools struggle to adapt to dynamic plant floor realities under Good Manufacturing Practices. Kaster's AI-powered production planning engine synchronises strategic plans with real-world operational constraints, whilst OPTEL provides validated real-time manufacturing intelligence. The solution has already been proven at one of Canada's largest sterile injectable manufacturing sites, demonstrating measurable improvements in production capacity, workflow efficiency and schedule stability. The partnership will make the technology available globally across OPTEL's operations in North America, Europe and Asia-Pacific.

PR Newswire
Feb 16th, 2026
OPTEL and Techno Service Forge Partnership to Deliver Pharmaceutical Track-and-Trace EDA Compliance in Egypt

OPTEL and Techno Service forge partnership to deliver pharmaceutical track-and-trace EDA compliance in Egypt. Feb 15, 2026, 23:03 ET CAIRO and QUEBEC CITY, Canada, Feb. 15, 2026 /PRNewswire/ - OPTEL, a global leader in track-and-trace solutions, and Techno Service, Egypt's premier industrial systems expert, today announced an exclusive partnership. The collaboration delivers a fully localized, end-to-end serialization and aggregation solution for pharmaceutical manufacturers and Third-Party Logistics (3PL) providers, combining OPTEL's proven global technology platform with Techno Service's deep local market expertise. Together, the companies offer compliant, cost-effective track-and-trace solutions supported by in-country integration and service, enabling Egyptian stakeholders to meet the Egyptian Drug Authority's (EDA) Unified National Electronic System for Pharmaceutical Track and Trace requirements ahead of the August 2026 regulatory deadline. OPTEL's track-and-trace solutions are deployed on more than 8,000 production lines across over 50 countries, supporting manufacturers in regulated environments worldwide. The solution integrates OPTEL's serialization and aggregation technology, manufactured in Germany, with local implementation and 24/7 technical support.This collaboration reflects OPTEL's long-term commitment to supporting regulated pharmaceutical markets with locally delivered compliance solutions. Addressing a Critical Market Need Pharmaceutical manufacturers in Egypt have often faced a trade-off between locally available systems with limited capabilities and advanced international platforms without strong in-country support. This partnership is designed to eliminate that constraint by combining a globally deployed track-and-trace platform with local engineering expertise and market-aligned pricing. "Serialization and aggregation systems must perform consistently under production pressure," said Louis Roy, CEO of OPTEL. "Our technology is built for high availability and stability, helping manufacturers maintain throughput while meeting EDA compliance requirements. As we evaluated the Egyptian market, it became clear that Techno Service's track record, technical depth, and long-standing presence made them the right partner to deliver this capability locally." Supporting Manual Aggregation and 3PL Operations A key focus of the partnership is support for manual and automated aggregation workflows, which remain critical for many manufacturers and 3PL providers in Egypt. The solution is designed to manage complex packaging hierarchies while integrating with existing production environments, minimizing disruption to current operations. Egypt-based since 1997, Techno Service brings extensive experience in deploying and supporting regulated industrial systems. Their engineering team will lead system integration and provide ongoing local service. "When we assessed the global track-and-trace landscape, OPTEL consistently stood out for the scale of its deployments and its reputation in regulated pharmaceutical markets," said Dr Mahmoud Othman, owner at Techno Service. "Their installed base and compliance expertise give Egyptian manufacturers access to a platform that is already trusted in highly regulated markets." About OPTEL OPTEL is a leading global provider of track-and-trace and vision systems, leveraging innovative technologies to create secure, efficient, and transparent supply chains. With more than 30 years of experience in track-and-trace compliance, OPTEL is a pioneer in vision inspection and traceability solutions for the life sciences industry and more.OPTEL tracks billions of products annually for leading brands. Founded in 1989, OPTEL is headquartered in Canada, with facilities in Germany, Ireland, India, and Brazil. For more information follow us on Linkedin or visit optelgroup.com About Techno Service Techno Service is a leading Egyptian company specializing in high-end machinery and advanced software solutions for the pharmaceutical, bio-pharmaceutical, agrochemical, oil & gas, and food & beverage industries. With a dedicated team of nearly 45 professionals, the company delivers comprehensive solutions encompassing sales, system integration, technical support, validation, and after-sales services. Backed by more than 28 years of market expertise, Techno Service has established a strong reputation as a trusted partner to many of Egypt's leading manufacturers, providing reliable technologies that enhance quality, ensure regulatory compliance, and drive operational excellence. https://technoservice-egypt.com/ SOURCE Optel Group

Optel Group
Oct 30th, 2025
OPTEL at CPhI Europe

OPTEL at CPhI Europe. Join OPTEL at the world's leading pharmaceutical event to explore next-generation traceability and vision technologies. From October 28 - 30, 2025, OPTEL will be exhibiting at CPhI Europe in Frankfurt, Germany - the global hub bringing together more than 62,000 visitors, 2,400 exhibitors, and pharmaceutical professionals from 166+ countries Optel Group invite you to visit Optel Group at Booth 9.0C71, Hall 9, where Optel Group will showcase its latest compliance, quality, and traceability solutions designed for the pharmaceutical industry. Experience OPTEL's Track-and-Trace and vision solutions. Its booth has been designed to highlight OPTEL's expertise in compliance, reliability, and supply chain visibility: * Track-and-Trace Turnkey Solutions * Serialization & aggregation (L1 - L5) * AI-powered vision systems * Global regulatory compliance (including DSCSA) * Vision Systems * Product inspection * Packaging inspection * Kit inspection * Labeling & printing inspection * Live Demonstrations Take your traceability strategy to the next level with OPTEL. Daily product demos. At CPhI, you will see OPTEL's solutions in action * Hardware Demos * All-in-One Carton Lite * Vial Inspection system * Software Demos * VerifyBrand: low-cost, multi-industry option * New OSM with AI Data Intelligence (R&D) * 3D demos on interactive touchscreen Why meet with OPTEL? For over 35 years, OPTEL has delivered more than 6,000 systems worldwide, helping pharmaceutical companies: * Ensure end-to-end traceability * Achieve global compliance * Improve efficiency and resilience in their operations Its team will be available for pre-booked meetings throughout the event. Don't miss the opportunity to discuss your specific challenges and explore tailored solutions.